Global Macrolide Antibiotics Market, By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories) – Industry Trends and Forecast to 2029
Global Macrolide Antibiotics Market Analysis and Size
Macrolide antibiotics are known to possess immunomodulatory and anti-inflammatory effects that are utilized for certain health conditions. The rise in the prevalence for infectious diseases is escalating the growth of macrolide antibiotics market.
- Global Macrolide Antibiotics Market was valued at USD 55,287.85 million in 2021 and is expected to reach USD 146,979.68 million by 2029, registering a CAGR of 13.00% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Macrolide Antibiotics Market Definition
Macrolides refer to a class of antibiotics that are derived from Saccharopolyspora erythraea, and inhibit protein synthesis in bacteria by binding to the 50S ribosomal element. These antibiotics are effective against gram positive bacteria and intracellular pathogens, such as Chlamydia and Mycoplasma and Legionella.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
GlaxoSmithKline plc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Lily. (US), Pfizer Inc. (US), Merck & Co., Inc. (US), Bristol-Myers Squibb Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Boehringer Ingelheim International Gmbh (Germany), Sanofi (France), Astrazeneca (UK), AbbVie Inc. (US), Abbott (US), Bayer AG (Germany), Sandoz International GmbH (Germany), Johnson & Johnson Services, Inc. (US), Zhejiang Guobang Pharmaceutical Co., Ltd. (China), and Barkat Pharmaceutical Group (Iran), among others
Macrolide Antibiotics Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Expansion of Antibiotics
The rapid expansion of antibiotics owing to the rising burden of infectious diseases across the globe acts as one of the major factors driving the growth of macrolide antibiotics market.
- Prevalence of Skin Infections
The rise in the prevalence of skin infections, such as cellulitis, erysipelas, and impetigo, among population accelerate the market growth.
- Funds and Grants
The surge in investments in the form of funds and grants for antibiotics further influence the market growth.
Furthermore, product innovations extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, supportive government policies will further expand the macrolide antibiotics market.
Restraints/Challenges Global Macrolide Antibiotics Market
On the other hand, availability of generic drugs and liver injuries caused by consumption of macrolide antibiotics are expected to obstruct market growth. Also, risk of sudden cardiovascular death in patients is projected to challenge the macrolide antibiotics market in the forecast period of 2022-2029.
This macrolide antibiotics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on macrolide antibiotics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Macrolide Antibiotics Market
The COVID-19 outbreak had an impact on the macrolide antibiotics market in the initial phase of the pandemic. Numerous clinics and pain services were no longer open for public services because of safety measures imposed by governments. In the latter half of the forecast period, the demand for macrolide antibiotics has risen owing to factors, including telemedicine that has become an appropriate and effective way to offer necessary medical services.
- Sandoz signed an agreement to acquire GSK’s cephalosporin antibiotics business, in February’2021 reinforcing leading position in antibiotics. The agreement confirms the Sandoz commitment to further grow its antibiotics business.
Global Macrolide Antibiotics Market Scope and Market Size
The macrolide antibiotics market is segmented on the basis of drugs, route of administration, infection and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Based on the drugs, the macrolide antibiotics market has been segmented into azithromycin, clarithromycin, erythromycin, fidaxomicin and telithromycin.
Route of Administration
Based on the route of administration, the macrolide antibiotics market has been segmented into oral and parenteral.
- Mycoplasma Pneumoniae
- Legionella Sp.
- Bordetella Pertussis
- Symptomatic Cat-Scratch Disease
- Bacillary Angiomatosis
- Cerebral Toxoplasmosis
- Uncomplicated Skin Infections
On the basis of infection, the macrolide antibiotics market is segmented into mycoplasma pneumoniae, legionella sp., bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosishepatis, cerebral toxoplasmosis and uncomplicated skin infections.
- Dermatology Clinic
- Ambulatory Centre
- Research Laboratories
On the basis of end user, the macrolide antibiotics market is segmented into hospital, dermatology clinic, clinic, ambulatory centre and research laboratories.
Macrolide Antibiotics Market Regional Analysis/Insights
The macrolide antibiotics market is analysed and market size insights and trends are provided by country, drugs, route of administration, infection and end user as referenced above.
The countries covered in the macrolide antibiotics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the macrolide antibiotics market because of the rise in prevalence of bacterial skin infection within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the growing awareness about the use of macrolides for the treatment of uncomplicated skin infections in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The macrolide antibiotics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for macrolide antibiotics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the macrolide antibiotics market. The data is available for historic period 2010-2020.
Competitive Landscape and Macrolide Antibiotics Market Share Analysis
The macrolide antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to macrolide antibiotics market.
Some of the major players operating in the macrolide antibiotics market are GlaxoSmithKline plc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Lily. (US), Pfizer Inc. (US), Merck & Co., Inc. (US), Bristol-Myers Squibb Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Boehringer Ingelheim International Gmbh (Germany), Sanofi (France), Astrazeneca (UK), AbbVie Inc. (US), Abbott (US), Bayer AG (Germany), Sandoz International GmbH (Germany), Johnson & Johnson Services, Inc. (US), Zhejiang Guobang Pharmaceutical Co., Ltd. (China), and Barkat Pharmaceutical Group (Iran), among others.
Research Methodology : Global Macrolide Antibiotics Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-macrolide-antibiotics-market
Customization Available : Global Macrolide Antibiotics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.